Remove FDA Remove Healthcare Remove Medical science
article thumbnail

How AI Can Help Medical Science Liaisons Juggle Their Ever-Growing Responsibilities

PM360

Traditionally, Medical Affairs has focused on cross-functional collaboration with commercial and R&D teams, medical communication, evidence generation, and dissemination. 1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade. But that’s just the beginning.

article thumbnail

Reducing real world data lag time for improved patient outcomes

Clarivate

In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. The Professional Society for Health Economics and Outcomes Research (ISPOR) has cited real world evidence (RWE) as the number one trend in healthcare decision making for the second year running [1].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

10 Ways AI/ML Technologies Can Enhance Software Quality in the Life Sciences Industry

PM360

Food & Drug Administration’s proposed Computer System Assurance (CSA) guidelines, the old methods of unit tests and standardized manual and automated testing are no longer adequate for ensuring both solution security and healthcare outcomes. The good news?

article thumbnail

Biologic Prices Decreasing As More Commercial Health Plans Allow Biosimilars as First-Line Options

PM360

When the first biosimilars were approved by the FDA almost a decade ago, they were expected to provide a cost-effective alternative to expensive biologics, improve accessibility for patients and reduce healthcare spending by creating competition in the biologic market. Regional Account Manager, and Shaun Terry, Sr.

article thumbnail

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Medgadget

The FDA looked at the data, saw it promising, and asked for a small feasibility study in the U.S. This will hopefully lead to an FDA approval for its first indication, after which Alpha TAU plans on expanding to other types of cancer and geographic regions such as Europe and Japan. The rest of the patients had partial responses.

article thumbnail

15 Top Venture Capital for Biotech Companies

Medico Reach

Technology and healthcare are two areas in which California-based New Enterprise Associates, Inc invests. OrbiMed Healthcare Fund Management. The New York-based OrbiMed Healthcare Fund Management has made various investments in the life sciences, including MedTech and biopharma. New Enterprise Associates. CEO : Luke Goh.

article thumbnail

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Medgadget

Interestingly, due to FDA’s regulatory methodology, surgical robots have to be approved for specific indications by the agency. Hundreds of Israeli life science firms will be showing off their products and technologies to attendees from all over the world. More info can be found at the Biomed Israel website.